RAGUSA ROBERT P 4

What Happened Robert P. Ragusa, a director of Twist Bioscience (TWST), was granted an annual equity award of 5,095 shares on 2026-02-05. The shares were issued at $0.00 (total reported value $0) as an award (transaction code A). This is a grant of compensation — not a purchase or sale — and does not represent an immediate cash transaction or market sale.

Key Details

• Transaction date: 2026-02-05; Form 4 filed: 2026-02-09 (timely under Form 4 rules).
• Amount: 5,095 shares granted at $0.00 per share (total $0 reported).
• Transaction type/code: Award/Grant (A).
• Vesting: Per the filing footnote, 100% of the shares will vest upon the earlier of (i) the one‑year anniversary of the grant or (ii) the first annual meeting of stockholders after the grant, provided Ragusa remains a service provider.
• Shares owned following the transaction: not specified in the provided filing excerpt.
• No indication of a tax-withholding sale, 10b5-1 plan, or immediate disposition in the filing.

Context Grants to non-employee directors are routine compensation and are typically intended to align directors with shareholder interests; they are not the same signal as an insider buying shares on the open market. The award vests only if the director remains in service through the vesting condition described, so the economic benefit is contingent on continued service.